Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Extension Study to Investigate Long Term Safety, Tolerability and Efficacy of Tauroursodeoxycholic Acid in Patients With ALS Who Completed the TUDCA-ALS Study

NCT05753852 is registered in ClinicalTrials.gov with Humanitas Mirasole SpA as lead sponsor.

NCT NCT05753852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05753852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Extension Study to Investigate Long Term Safety, Tolerability and Efficacy of Tauroursodeoxycholic Acid in Patients With ALS Who Completed the TUDCA-ALS Study
Lead sponsor
Humanitas Mirasole SpA
Phase
Phase 3
Overall status
Unknown status
Start date
October 25, 2021
Completion date
March 31, 2025
Enrollment
184 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis